HIGH Altitude CArdiovascular REsearch in the ANDES

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01830530

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01830530
Other papers using this trial's data
  • Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study Hypertension (Dallas, Tex. : 1979), 2015-06 DOI, PubMed 25895588
  • Upward Shift and Steepening of the Blood Pressure Response to Exercise in Hypertensive Subjects at High Altitude Journal of the American Heart Association, 2018-06-09 DOI, PubMed 29886423, PMC6220550 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Peru (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01830530. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
HIGH Altitude CArdiovascular REsearch in the ANDES
Acronym
HIGHCARE-A
Condition
Hypertension
Condition
High Altitude
Intervention (Drug)
Telmisartan
Intervention (Drug)
Nifedipine
Intervention (Drug)
placebo
Lead sponsor
Istituto Auxologico Italiano (class: other)
Collaborator
Bayer (class: industry)

Record details

Record id
cardio:ct-nct01830530
Content hash
5257b892297ff0c444971139e136eea421032a277055daf9f679fe779eebab4c